208 related articles for article (PubMed ID: 27732942)
1. Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
Alexander-Savino CV; Hayden MS; Richardson C; Zhao J; Poligone B
Oncotarget; 2016 Nov; 7(46):75954-75967. PubMed ID: 27732942
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study.
Wu J; Wood GS
JAMA Dermatol; 2018 Oct; 154(10):1191-1198. PubMed ID: 30167641
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis.
Izban KF; Ergin M; Qin JZ; Martinez RL; Pooley RJ JR; Saeed S; Alkan S
Hum Pathol; 2000 Dec; 31(12):1482-90. PubMed ID: 11150373
[TBL] [Abstract][Full Text] [Related]
6. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
7. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
Shishodia S; Amin HM; Lai R; Aggarwal BB
Biochem Pharmacol; 2005 Sep; 70(5):700-13. PubMed ID: 16023083
[TBL] [Abstract][Full Text] [Related]
8. Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma.
Gallardo F; Bertran J; López-Arribillaga E; González J; Menéndez S; Sánchez I; Colomo L; Iglesias M; Garrido M; Santamaría-Babí LF; Torres F; Pujol RM; Bigas A; Espinosa L
Leukemia; 2018 Oct; 32(10):2211-2223. PubMed ID: 29511289
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
[TBL] [Abstract][Full Text] [Related]
10. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.
Sors A; Jean-Louis F; Pellet C; Laroche L; Dubertret L; Courtois G; Bachelez H; Michel L
Blood; 2006 Mar; 107(6):2354-63. PubMed ID: 16219794
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
13. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
14. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.
Kamstrup MR; Gjerdrum LM; Biskup E; Lauenborg BT; Ralfkiaer E; Woetmann A; Ødum N; Gniadecki R
Blood; 2010 Oct; 116(14):2504-12. PubMed ID: 20538790
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells.
Ogut D; Reel B; Gonen Korkmaz C; Arun MZ; Cilaker Micili S; Ergur BU
Folia Histochem Cytobiol; 2016; 54(4):171-180. PubMed ID: 27966209
[TBL] [Abstract][Full Text] [Related]
16. HA14-1 sensitizes TNF-alpha-induced apoptosis via inhibition of the NF-kappaB signaling pathway: involvement of reactive oxygen species and JNK.
Moon DO; Kim MO; Kang SH; Choi YH; Park SY; Kim GY
Cancer Lett; 2010 Jun; 292(1):111-8. PubMed ID: 20022690
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.
Nicolay JP; Müller-Decker K; Schroeder A; Brechmann M; Möbs M; Géraud C; Assaf C; Goerdt S; Krammer PH; Gülow K
Blood; 2016 Aug; 128(6):805-15. PubMed ID: 27268084
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates.
Manna SK; Aggarwal BB
J Immunol; 1999 Feb; 162(3):1510-8. PubMed ID: 9973408
[TBL] [Abstract][Full Text] [Related]
19. Role of NF-kappaB signaling pathway in increased tumor necrosis factor-alpha-induced apoptosis of lymphocytes in aged humans.
Gupta S; Bi R; Kim C; Chiplunkar S; Yel L; Gollapudi S
Cell Death Differ; 2005 Feb; 12(2):177-83. PubMed ID: 15647756
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
